SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-C - Written communication relating to an issuer or third party:
SEC Accession No. 0000950103-15-000254
Filing Date
2015-01-12
Accepted
2015-01-12 17:11:06
Documents
2
Group Members
KNIGHT NEWCO 2, INC.SHIRE PLC

Document Format Files

Seq Description Document Type Size
1 FORM SC TO-C dp52533_sctoc.htm SC TO-C 24465
2 GRAPHIC logo.jpg GRAPHIC 12072
  Complete submission text file 0000950103-15-000254.txt   42778
Mailing Address 550 HILLS DRIVE BEDMINSTER NJ 07921
Business Address 550 HILLS DRIVE BEDMINSTER NJ 07921 (908) 450-5300
NPS PHARMACEUTICALS INC (Subject) CIK: 0000890465 (see all company filings)

IRS No.: 870439579 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-C | Act: 34 | File No.: 005-44877 | Film No.: 15522611
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 5 RIVERWALK, CITYWEST BUSINESS CAMPUS DUBLIN L2 24
Business Address 5 RIVERWALK, CITYWEST BUSINESS CAMPUS DUBLIN L2 24 353-1-429-7700
Shire Pharmaceutical Holdings Ireland Ltd. (Filed by) CIK: 0001590310 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: SC TO-C